Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical foams to address unmet needs in dermatology.
Our clinical stage product candidates include FMX101, our novel minocycline foam for the treatment of moderate-to-severe acne, FMX103 for the treatment of moderate-to-severe rosacea.
Company Details
- Employees
- 29
- Founded
- -
- Address
- 2 Holzman Street,
- Phone
- (972) 893-1623
- do****@****rma.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- foamix.com
- Keywords
- Formulation, Topical, Dermatology, Foam, Skin, Psoriasis, Atopic Dermatitis, Acne, Rosacea, Wound.
- HQ
- Rehovot
Foamix Pharmaceuticals Questions
Foamix Pharmaceuticals's helpline number is (972) 893-1623
Foamix Pharmaceuticals's website is foamix.com
Foamix Pharmaceuticals's LinkedIn profile is https://www.linkedin.com/company/foamix-pharmaceuticals
Foamix Pharmaceuticals has
29 employees.
View email and phone details for 29
employees at Foamix Pharmaceuticals.
Foamix Pharmaceuticals's industry is
Pharmaceutical Manufacturing
Foamix Pharmaceuticals's top competitors are
Evogene,
Mediwound,
Vyne Therapeutics Inc.,
Saghmos Therapeutics,
Biodundee,
Omrix Biosurgery Israel,
Tay Therapeutics Ltd,
Kamada,
Anima Biotech,
Dexcel Pharma.
Foamix Pharmaceuticals's support email address is dov.tamarkin@foamixpharma.com
Foamix Pharmaceuticals's categories are Pharmaceutical Manufacturing
Foamix Pharmaceuticals's founding year is 2003
